Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2025-12-25 @ 3:08 PM
NCT ID:
NCT01296568
Group ID:
EG001
Title:
LY2603618 + Gemcitabine
Description:
Adverse events reported during the second phase of the study. After completing the first phase \[a single 250 milligram (mg) intravenous dose of LY2603618 containing \[\^14C\]LY2603618 followed by a minimum 7-day washout period\], participants received Gemcitabine 1000 milligrams per square meter (mg/m\^2) administered intravenously on Days 1, 8, and 15 with 230 mg LY2603618 administered intravenously on Days 2, 9 and 16 of a 28-day cycle until unacceptable toxicity or disease progression.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
3
Other Number Affected:
3
Other Number At Risk:
3
Study:
NCT01296568
Results Section:
NCT01296568
Adverse Events Module:
NCT01296568